Welcome to our dedicated page for Kewaunee Scienti news (Ticker: KEQU), a resource for investors and traders seeking the latest updates and insights on Kewaunee Scienti stock.
Kewaunee Scientific Corporation (KEQU) delivers specialized laboratory furniture and technical workspace solutions for research, healthcare, and education sectors worldwide. This news hub provides investors and industry professionals with essential updates on the company's strategic developments, product innovations, and market leadership in scientific workspace design.
Access authoritative information including earnings announcements, facility expansions, product line enhancements, and leadership updates. Our curated collection features official press releases and verified news about KEQU's steel/wood cabinetry systems, modular laboratory installations, and international project deployments.
Key updates cover manufacturing advancements, sustainability initiatives, and partnerships driving innovation in laboratory safety and functionality. Bookmark this page for streamlined tracking of KEQU's progress in serving research institutions, healthcare networks, and technical education facilities globally.
Kewaunee Scientific (NASDAQ: KEQU) announced plans to release financial results for its fourth quarter and fiscal year ended April 30, 2024, on June 26, 2024, after market close. These results will be accessible on the company's website. Founded in 1906, Kewaunee is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products. The company operates three manufacturing facilities in Statesville, North Carolina, and one in Bangalore, India, serving both domestic and international markets. Sales offices are located in the U.S., India, Saudi Arabia, and Singapore.
Kewaunee Scientific Corporation (NASDAQ: KEQU) reported a 49.7% year-over-year increase in third-quarter sales for FY 2023, reaching $60,821,000. Pre-tax earnings turned positive at $2,060,000, compared to a loss of $887,000 last year. Net earnings also improved to $723,000, reversing a net loss of $1,319,000. EBITDA climbed to $2,683,000 from a negative $117,000. The order backlog grew to $153.2 million, bolstered by a multi-year contract with Indian Oil Corporation. Domestic sales rose by 22.4%, while international sales surged by 122.4%. Cash on hand increased to $18,416,000, marking a significant rise from $6,894,000 a year prior.
Kewaunee Scientific Corporation (NASDAQ: KEQU) announced a significant contract from Indian Oil Corporation Limited (IOCL) for laboratory furniture and technical products at IOCL's new R&D facility in Faridabad, India. This project, awarded by Shapoorji Pallonji Ltd., emphasizes Kewaunee's robust market position in India’s laboratory infrastructure sector. The contract enhances the company's order backlog, which will be reported in the upcoming Q3 earnings release on March 8, 2023. Kewaunee reiterated its commitment to delivering advanced laboratory solutions and acknowledged the ongoing investment in India's expanding economy.
FAQ
What is the current stock price of Kewaunee Scienti (KEQU)?
What is the market cap of Kewaunee Scienti (KEQU)?
